Logo image of AHR

AMERICAN HEALTHCARE REIT INC (AHR) Stock Fundamental Analysis

NYSE:AHR - New York Stock Exchange, Inc. - US3981823038 - REIT - Currency: USD

30.44  +0.65 (+2.18%)

Premarket: 31.1 +0.66 (+2.17%)

Fundamental Rating

2

Taking everything into account, AHR scores 2 out of 10 in our fundamental rating. AHR was compared to 129 industry peers in the Diversified REITs industry. AHR has a bad profitability rating. Also its financial health evaluation is rather negative. AHR does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

AHR had positive earnings in the past year.
AHR had a positive operating cash flow in the past year.
AHR Yearly Net Income VS EBIT VS OCF VS FCFAHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 0 50M -50M 100M -100M

1.2 Ratios

AHR has a worse Return On Assets (-0.72%) than 69.05% of its industry peers.
With a Return On Equity value of -1.52%, AHR is not doing good in the industry: 65.87% of the companies in the same industry are doing better.
AHR has a Return On Invested Capital of 2.35%. This is in the lower half of the industry: AHR underperforms 62.70% of its industry peers.
AHR had an Average Return On Invested Capital over the past 3 years of 1.28%. This is in line with the industry average of 3.15%.
The last Return On Invested Capital (2.35%) for AHR is above the 3 year average (1.28%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.72%
ROE -1.52%
ROIC 2.35%
ROA(3y)-1.43%
ROA(5y)N/A
ROE(3y)-4.82%
ROE(5y)N/A
ROIC(3y)1.28%
ROIC(5y)N/A
AHR Yearly ROA, ROE, ROICAHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 0 -2 -4

1.3 Margins

With a Operating Margin value of 6.26%, AHR is not doing good in the industry: 85.71% of the companies in the same industry are doing better.
The Gross Margin of AHR (20.00%) is worse than 94.44% of its industry peers.
Industry RankSector Rank
OM 6.26%
PM (TTM) N/A
GM 20%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
AHR Yearly Profit, Operating, Gross MarginsAHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 0 5 10 15 20

More info and screens

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AHR is destroying value.
AHR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
AHR Yearly Shares OutstandingAHR Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 20M 40M 60M
AHR Yearly Total Debt VS Total AssetsAHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 1B 2B 3B 4B

2.2 Solvency

AHR has an Altman-Z score of 1.19. This is a bad value and indicates that AHR is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of 1.19, AHR belongs to the top of the industry, outperforming 80.16% of the companies in the same industry.
The Debt to FCF ratio of AHR is 743.75, which is on the high side as it means it would take AHR, 743.75 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 743.75, AHR perfoms like the industry average, outperforming 46.83% of the companies in the same industry.
AHR has a Debt/Equity ratio of 0.87. This is a neutral value indicating AHR is somewhat dependend on debt financing.
The Debt to Equity ratio of AHR (0.87) is better than 67.46% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 743.75
Altman-Z 1.19
ROIC/WACC0.32
WACC7.43%
AHR Yearly LT Debt VS Equity VS FCFAHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 0 500M 1B 1.5B 2B 2.5B

2.3 Liquidity

AHR has a Current Ratio of 0.61. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Current ratio value of 0.61, AHR is not doing good in the industry: 78.57% of the companies in the same industry are doing better.
AHR has a Quick Ratio of 0.61. This is a bad value and indicates that AHR is not financially healthy enough and could expect problems in meeting its short term obligations.
AHR has a Quick ratio of 0.61. This is in the lower half of the industry: AHR underperforms 76.98% of its industry peers.
Industry RankSector Rank
Current Ratio 0.61
Quick Ratio 0.61
AHR Yearly Current Assets VS Current LiabilitesAHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 100M 200M 300M 400M 500M

More info and screens

3

3. Growth

3.1 Past

EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%197.56%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.47%

3.2 Future

The Earnings Per Share is expected to grow by 37.34% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 8.25% on average over the next years. This is quite good.
EPS Next Y14.37%
EPS Next 2Y37.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year9.49%
Revenue Next 2Y8.25%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

AHR Yearly Revenue VS EstimatesAHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
AHR Yearly EPS VS EstimatesAHR Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 0 0.5 -0.5

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 89.53, AHR can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of AHR indicates a slightly more expensive valuation: AHR is more expensive than 61.90% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 29.75, AHR is valued quite expensively.
AHR is valuated quite expensively with a Price/Forward Earnings ratio of 78.28.
AHR's Price/Forward Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.44, AHR is valued quite expensively.
Industry RankSector Rank
PE 89.53
Fwd PE 78.28
AHR Price Earnings VS Forward Price EarningsAHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AHR is valued more expensive than 88.10% of the companies in the same industry.
AHR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 1806.57
EV/EBITDA 21.55
AHR Per share dataAHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as AHR's earnings are expected to grow with 37.34% in the coming years.
PEG (NY)6.23
PEG (5Y)N/A
EPS Next 2Y37.34%
EPS Next 3YN/A

More info and screens

1

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 3.36%, AHR has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 19.13, AHR is paying slightly less dividend.
AHR's Dividend Yield is a higher than the S&P500 average which is at 2.30.
Industry RankSector Rank
Dividend Yield 3.36%

5.2 History

AHR is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
AHR Yearly Dividends per shareAHR Yearly Dividends per shareYearly Dividends per share 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

The earnings of AHR are negative and hence is the payout ratio. AHR will probably not be able to sustain this dividend level.
DP-296.41%
EPS Next 2Y37.34%
EPS Next 3YN/A
AHR Yearly Income VS Free CF VS DividendAHR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2021 2022 2023 0 50M -50M -100M

More info and screens

AMERICAN HEALTHCARE REIT INC

NYSE:AHR (3/3/2025, 8:11:26 PM)

Premarket: 31.1 +0.66 (+2.17%)

30.44

+0.65 (+2.18%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)02-27 2025-02-27/amc
Earnings (Next)N/A N/A
Inst Owners98.42%
Inst Owner Change13.95%
Ins Owners0.82%
Ins Owner Change-8.45%
Market Cap4.66B
Analysts81.67
Price Target33.15 (8.9%)
Short Float %4.4%
Short Ratio3.74
Dividend
Industry RankSector Rank
Dividend Yield 3.36%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-296.41%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.62%
Min Revenue beat(2)-1.61%
Max Revenue beat(2)6.85%
Revenue beat(4)3
Avg Revenue beat(4)1.68%
Min Revenue beat(4)-1.61%
Max Revenue beat(4)6.85%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)10.78%
EPS NQ rev (1m)0%
EPS NQ rev (3m)45.45%
EPS NY rev (1m)0%
EPS NY rev (3m)283.33%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.53%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.68%
Valuation
Industry RankSector Rank
PE 89.53
Fwd PE 78.28
P/S 2.32
P/FCF 1806.57
P/OCF 32.73
P/B 2.11
P/tB 2.6
EV/EBITDA 21.55
EPS(TTM)0.34
EY1.12%
EPS(NY)0.39
Fwd EY1.28%
FCF(TTM)0.02
FCFY0.06%
OCF(TTM)0.93
OCFY3.06%
SpS13.14
BVpS14.42
TBVpS11.73
PEG (NY)6.23
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.72%
ROE -1.52%
ROCE 2.97%
ROIC 2.35%
ROICexc 2.39%
ROICexgc 2.68%
OM 6.26%
PM (TTM) N/A
GM 20%
FCFM 0.13%
ROA(3y)-1.43%
ROA(5y)N/A
ROE(3y)-4.82%
ROE(5y)N/A
ROIC(3y)1.28%
ROIC(5y)N/A
ROICexc(3y)1.3%
ROICexc(5y)N/A
ROICexgc(3y)1.47%
ROICexgc(5y)N/A
ROCE(3y)1.62%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0.43
Health
Industry RankSector Rank
Debt/Equity 0.87
Debt/FCF 743.75
Debt/EBITDA 6.35
Cap/Depr 79.31%
Cap/Sales 6.95%
Interest Coverage 0.97
Cash Conversion 47.12%
Profit Quality N/A
Current Ratio 0.61
Quick Ratio 0.61
Altman-Z 1.19
F-Score6
WACC7.43%
ROIC/WACC0.32
Cap/Depr(3y)95.22%
Cap/Depr(5y)N/A
Cap/Sales(3y)9.68%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)N/A
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%197.56%
EPS Next Y14.37%
EPS Next 2Y37.34%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%12.47%
Revenue Next Year9.49%
Revenue Next 2Y8.25%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-15.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year442.37%
EBIT Next 3Y87.91%
EBIT Next 5YN/A
FCF growth 1Y-1644.82%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-33.32%
OCF growth 3YN/A
OCF growth 5YN/A